<DOC>
	<DOCNO>NCT01291472</DOCNO>
	<brief_summary>The purpose study : - document ketorolac disposition ( concentration/time profile , protein binding , metabolism ) covariates follow intravenous ( iv ) administration ketorolac right caesarean section compare observation ( n=32 ) non-pregnant state ( n=8 ) ( intra-subject PK comparison ) - document biochemical tolerance ketorolac - evaluate optimalisation ketorolac dose regimen pregnancy labor appropriate need - quantify neonatal exposure ketorolac excretion breast milk</brief_summary>
	<brief_title>Disposition Intravenous Ketorolac</brief_title>
	<detailed_description>Prospective , single-center , open label study pharmacokinetics intravenous ( iv ) ketorolac administration pregnant woman right caesarean section . Patients include sign informed consent . Ketorolac select study routinely administer postoperative pain relief . At stage , intention document ketorolac pharmacokinetics metabolism base dose regimen currently use clinical setting , therefore interfere either clinical indication , dose prescribe attend physician . This drug routinely administer ( 30 mg q8h ) caesarean section . Drug administration collection sample obtain current clinical nursing standard procedure . After dilution 50-100 ml bag normal saline drug administer caesarean section iv bolus , peripherally insert venous catheter , 30 mg , 3 time one day . The intended duration administration 5-10 minute . Blood sample collect ( heparinised tube ) accord follow schedule : 1 , 2 , 3 , 4 , 6 8 hour iv administration , second peripherally insert venous catheter dedicate blood sample . Blood sample centrifuge immediately collection subsequently store -20 Â°C analysis . Urine sample also collect , drug administration first 8 hour first drug administration , bladder catheter patient bladder catheter available clinical indication . In subgroup former patient ( n=8 ) , plan repeat procedure 6-12 week delivery ( intra-subject PK comparison ) . However , single iv ketorolac dose administer , sample limit 6 sample 8 h follow start iv administration . A population pharmacokinetics approach use , hereby compare data PK already report adult newly collect data follow pregnancy .</detailed_description>
	<mesh_term>Pain , Postoperative</mesh_term>
	<mesh_term>Ketorolac</mesh_term>
	<mesh_term>Ketorolac Tromethamine</mesh_term>
	<criteria>sign informed write consent pregnant woman ketorolac administer intravenous route clinical indication preferable availability revision 612 week delivery ( around routine postdelivery checkup ) . withdrawal inform write consent know NSAID 's intolerance</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>February 2011</verification_date>
	<keyword>ketorolac</keyword>
	<keyword>pain</keyword>
	<keyword>pregnancy</keyword>
	<keyword>non-pregnant state</keyword>
</DOC>